Pharmacists Can Now Dispense Mifepristone Under Updated REMS Program
Birth Control Pharmacist
JANUARY 19, 2023
As of January 2023, the US Food and Drug Administration (FDA) announced an update to the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone. This update is expected to alleviate the burden on patients and make medication abortion care more accessible. The other component of the medication abortion regimen is misoprostol.
Let's personalize your content